Alpha Tau Medical (DRTS) Operating Leases (2022 - 2026)
Alpha Tau Medical (DRTS) posted Operating Leases of $6.7 million for Q1 2026, up 7.91% sequentially from $6.2 million in Q4 2025, and up 15.76% YoY from $5.8 million in Q1 2025.
Alpha Tau Medical (DRTS) Operating Leases (2022 - 2026) Analysis & Trends
Alpha Tau Medical has reported Operating Leases for 5 years, with the latest figure at $6.7 million in Q1 2026.
- Quarterly Operating Leases rose 15.76% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 15.76% YoY) and the FY2025 annual result came in at $6.2 million, up 4.68% from the prior year.
- Operating Leases grew to $6.7 million in Q1 2026 per DRTS's latest filing, from $6.2 million in the prior quarter.
- Over five years, Operating Leases peaked at $6.7 million in Q1 2026 and troughed at $4.5 million in Q4 2022.
- A 5-year average of $5.9 million and a median of $6.1 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases soared 45.98% in 2023, then fell 9.69% in 2024.
- Over 5 years, Operating Leases stood at $4.5 million in 2022, then surged by 45.98% to $6.6 million in 2023, then dropped by 9.69% to $6.0 million in 2024, then increased by 4.68% to $6.2 million in 2025, then gained by 7.91% to $6.7 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $6.7 million, $6.2 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.35 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 6.24 Mn |
| Sep 30, 2025 | 6.23 Mn |
| Jun 30, 2025 | 6.20 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Dec 31, 2024 | 5.96 Mn |
| Sep 30, 2024 | 6.06 Mn |
| Jun 30, 2024 | 6.11 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 6.60 Mn |
| Sep 30, 2023 | 5.20 Mn |
| Jun 30, 2023 | 5.43 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 4.52 Mn |